fig3

Prussian blue nanozyme for ischemia-reperfusion injury treatment: progress, opportunities and challenges

Figure 3. The neutral granulocytes loaded with metformin are coated with PBNZ (Met@PBN@Neu-CVs), which effectively alleviate hepatic ischemia-reperfusion injury (HIRI). (A) Schematic diagram of the synthesis and administration of Met@PBN@Neu-CVs for HIRI treatment; (B) Therapeutic effect of Met@PBN@Neu-CVs on liver IRI in rats. This figure is quoted with permission from Shen et al.[66]. Here, * vs. Sham; # vs. IRI; & vs. IRI + Met; % vs. IRI + PBN@Neu-CVs, P < 0.05, N = 5.

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/